Using a publicly available database, we have shown that GSDMD mRNA is overexpressed in different types of cancer, including breast cancer, bladder cancer, esophageal cancer, stomach cancer, glioblastoma, head and neck cancer, renal cell carcinoma, and hepatocellular carcinoma, supporting and extending previous findings in several types of cancer (31–33). Here, GSDMD is linked to hepatocellular carcinoma.